Abstract：
BACKGROUND: Dysmenorrhea, or menstrual pain, is a subjective experience, and can only be assessed by patient-reported outcomes. These instruments should be reliable, valid and responsive.
OBJECTIVE: To identify and critically appraise the available evidence for the measurement properties of specific patient-reported outcome measures used for dysmenorrhea.
METHODS: The PRISMA statement was used to report this systematic review. Databases searched were PubMed, SCOPUS, CINAHL, Web of Science, ScienceDirect and Google Scholar (April 2021; updated on February 2023). Original studies with primary data collection, with no restriction on language and publication date that reported psychometric properties of one or more dysmenorrhea-related patient-reported outcome measure. The literature searches, selection of studies, data extraction and assessment of the risk of bias were performed independently by two reviewers and followed the COSMIN guidelines.
RESULTS: Thirty studies were analysed in this review, and 19 patient-reported outcome measures were evaluated. The instruments varied in relation to the measured construct and measurement properties (validity, reliability and responsiveness). The methodological quality of the studies and the quality of evidence of the patient-reported outcome measures were variable. Among the 13 studies that reported the development of patient-reported outcome measures, most had inadequate methodological quality, and the overall rating was insufficient or inconsistent.
CONCLUSIONS: The Dysmenorrhea Symptom Interference (DSI) scale was the only identified patient-reported outcome measure that has the potential to be recommended because of its sufficient rating combined with moderate quality of evidence for content validity. Future studies should further evaluate the measurement properties of the existing patient-reported outcome measures, or develop new patient-reported outcome measures following the COSMIN methodology.
UNASSIGNED: Not applicable as this is a systematic review.
BACKGROUND: PROSPERO protocol: CRD42021244410. Registration on April 22, 2021.
OBJECTIVE: To identify and critically appraise the available evidence for the measurement properties of specific patient-reported outcome measures used for dysmenorrhea.
METHODS: The PRISMA statement was used to report this systematic review. Databases searched were PubMed, SCOPUS, CINAHL, Web of Science, ScienceDirect and Google Scholar (April 2021; updated on February 2023). Original studies with primary data collection, with no restriction on language and publication date that reported psychometric properties of one or more dysmenorrhea-related patient-reported outcome measure. The literature searches, selection of studies, data extraction and assessment of the risk of bias were performed independently by two reviewers and followed the COSMIN guidelines.
RESULTS: Thirty studies were analysed in this review, and 19 patient-reported outcome measures were evaluated. The instruments varied in relation to the measured construct and measurement properties (validity, reliability and responsiveness). The methodological quality of the studies and the quality of evidence of the patient-reported outcome measures were variable. Among the 13 studies that reported the development of patient-reported outcome measures, most had inadequate methodological quality, and the overall rating was insufficient or inconsistent.
CONCLUSIONS: The Dysmenorrhea Symptom Interference (DSI) scale was the only identified patient-reported outcome measure that has the potential to be recommended because of its sufficient rating combined with moderate quality of evidence for content validity. Future studies should further evaluate the measurement properties of the existing patient-reported outcome measures, or develop new patient-reported outcome measures following the COSMIN methodology.
UNASSIGNED: Not applicable as this is a systematic review.
BACKGROUND: PROSPERO protocol: CRD42021244410. Registration on April 22, 2021.
摘要：
背景：痛经，或月经疼痛，是一种主观体验，并且只能通过患者报告的结果进行评估。这些仪器应该是可靠的，有效和响应。
目的：确定并严格评估用于痛经的特定患者报告结局指标的测量特性的现有证据。
方法：使用PRISMA声明报告本系统综述。搜索的数据库是PubMed，Scopus,CINAHL,WebofScience,ScienceDirect和GoogleScholar（2021年4月；2023年2月更新）。原始研究与主要数据收集，对报告一种或多种痛经相关患者报告结局指标的心理测量特性的语言和出版日期没有限制。文献检索,选择研究，数据提取和偏倚风险评估由两名评审员独立进行,并遵循COSMIN指南.
结果：这篇综述分析了30项研究，评估了19项患者报告的结局指标.仪器在测量结构和测量特性方面有所不同(有效性，可靠性和响应性)。研究的方法学质量和患者报告的结局指标的证据质量是可变的。在报告患者报告结果指标发展的13项研究中，大多数方法质量不足，总体评级不足或不一致。
结论：痛经症状干扰（DSI）量表是唯一已确定的患者报告的结局指标，由于其足够的评级以及中等质量的证据，具有推荐的潜力。未来的研究应进一步评估现有患者报告的结果指标的测量特性，或根据COSMIN方法开发新的患者报告结局指标。
■不适用，因为这是一个系统的审查。
背景：PROSPERO协议：CRD42021244410。2021年4月22日注册。
目的：确定并严格评估用于痛经的特定患者报告结局指标的测量特性的现有证据。
方法：使用PRISMA声明报告本系统综述。搜索的数据库是PubMed，Scopus,CINAHL,WebofScience,ScienceDirect和GoogleScholar（2021年4月；2023年2月更新）。原始研究与主要数据收集，对报告一种或多种痛经相关患者报告结局指标的心理测量特性的语言和出版日期没有限制。文献检索,选择研究，数据提取和偏倚风险评估由两名评审员独立进行,并遵循COSMIN指南.
结果：这篇综述分析了30项研究，评估了19项患者报告的结局指标.仪器在测量结构和测量特性方面有所不同(有效性，可靠性和响应性)。研究的方法学质量和患者报告的结局指标的证据质量是可变的。在报告患者报告结果指标发展的13项研究中，大多数方法质量不足，总体评级不足或不一致。
结论：痛经症状干扰（DSI）量表是唯一已确定的患者报告的结局指标，由于其足够的评级以及中等质量的证据，具有推荐的潜力。未来的研究应进一步评估现有患者报告的结果指标的测量特性，或根据COSMIN方法开发新的患者报告结局指标。
■不适用，因为这是一个系统的审查。
背景：PROSPERO协议：CRD42021244410。2021年4月22日注册。
